Functions of CD40 and its Ligand, gp39 (CD40L)

被引:143
|
作者
Laman, JD
Claassen, E
Noelle, RJ
机构
[1] DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756
[2] TNO PREVENT & HLTH,DIV INFECT DIS & IMMUNOL,2301 CE LEIDEN,NETHERLANDS
关键词
CD40; Ligand; gp39; lymphocyte activation; signal transduction; tolerance; cognate T and B cell interaction; antibody; isotype switching; autoimmunity; immunotherapy;
D O I
10.1615/CritRevImmunol.v16.i1.40
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Initially, a role for the interaction between CD40, expressed on B cells, and gp39 (CD40L), expressed on activated T cells, has been defined in humoral immunity. CD40-CD40L interaction is an essential signal for B cell proliferation, expression of activation markers, immunoglobulin production, and isotype switching. CD40-CD40L interaction is also required for formation of B memory cells and germinal centers, and signaling through CD40 prevents apoptosis of germinal center B cells. Defective expression of CD40L in humans leads to an inability to produce isotypes other than IgM (hyper IgM syndrome), and to an absence of germinal centers. More recent evidence indicates an expansion of the role of the CD40-CD40L axis in cellular interactions beyond antibody formation. Induced expression of CD40 on monocytes can lead to CD40L-activated monocyte effector mechanisms. In addition, CD40-CD40L interactions are crucially involved in development of autoimmune disease in a number of animal models. CD40-CD40L interactions also impact on growth regulation of certain carcinomas. Manipulation of CD40L has also been used to develop novel strategies for long-term antigen-specific tolerization of peripheral T cells. Finally, the CD40-CD40L axis is involved in thymic selection. Following is a comprehensive overview of CD40L-CD40 interactions in physiological and pathogenic cellular responses and a discussion of the therapeutic ramifications of these interactions.
引用
收藏
页码:59 / 108
页数:50
相关论文
共 50 条
  • [31] CD40/CD40L and cardiovascular risk in patients on haemodialysis: a role for soluble CD40?
    Esposito, Pasquale
    Dal Canton, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (07) : 2414 - 2415
  • [32] Platelet activation by a humanized monoclonal CD40 ligand (CD40L) antibody.
    Meyer, Todd
    Amirkhosravi, Ali
    Robson, Theresa
    Amaya, Mildred
    Hina, Desai
    Su, Lihe
    Hsu, Yen-Ming
    Langer, Florian
    Francis, John L.
    BLOOD, 2006, 108 (11) : 437A - 437A
  • [33] GAMMA/DELTA-T-LYMPHOCYTES EXPRESS CD40 LIGAND (CD40L)
    HORNER, AA
    RAMESH, N
    AHERN, D
    FULEIHAN, R
    GEHA, RS
    FASEB JOURNAL, 1994, 8 (05): : A1014 - A1014
  • [34] Regulation of CD40 Ligand (CD40L) mRNA stability by Protein Kinase C
    Castro, Moraima
    Matus-Nicodemos, Rodrigo
    Covey, Lori
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [35] The multi-functionality of CD40L and its receptor CD40 in atherosclerosis
    Lievens, Dirk
    Eijgelaar, Wouter J.
    Biessen, Erik A. L.
    Daemen, Mat J. A. P.
    Lutgens, Esther
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) : 206 - 214
  • [36] CD40/CD40L expression and its prognostic value in cervical cancer
    Grazia, G. A.
    Bastos, D. R.
    Villa, L. L.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2023, 56
  • [37] Ligation of CD40 induces high level expression of CD40 ligand (CD40l) on peripheral blood B lymphocytes.
    Santiago-Schwarz, F
    Tucci, J
    Carsons, SE
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S36 - S36
  • [38] The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease
    Parsaud, Leon
    Arjmand, Parnian
    Duong, Trang T.
    Yeung, Rae S.
    CIRCULATION, 2015, 131
  • [39] Irradiation of CD40 and CD40L in inflammatory liver disease
    Leifeld, L
    Dumoulin, FL
    Ramakers, J
    Wolff, M
    Sauerbruch, T
    Spengler, U
    GASTROENTEROLOGY, 1997, 112 (04) : A1318 - A1318
  • [40] A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity
    Gunaydin, Nursen C.
    Chou, Janet
    Karaca, Neslihan E.
    Aksu, Guzide
    Massaad, Michel J.
    Azarsiz, Elif
    Ertan, Yesim
    Geha, Ralf S.
    Kutukculer, Necil
    CLINICAL IMMUNOLOGY, 2014, 153 (02) : 288 - 291